SYK Stryker Corp

Price (delayed)

$263.92

Market cap

$99.29B

P/E Ratio

61.95

Dividend/share

$2.41

EPS

$4.26

Enterprise value

$110.33B

Sector: Healthcare
Industry: Medical Devices

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; ...

Highlights

SYK's equity is up by 2.2% year-on-year
SYK's P/E is 70% above its 5-year quarterly average of 36.4 and 44% above its last 4 quarters average of 43.2
SYK's quick ratio is down by 44% from the previous quarter and by 31% YoY

Key stats

What are the main financial stats of SYK
Market
Shares outstanding
376.2M
Market cap
$99.29B
Enterprise value
$110.33B
Valuations
Price to earnings (P/E)
61.95
Price to book (P/B)
7.58
Price to sales (P/S)
6.91
EV/EBIT
56.47
EV/EBITDA
48.1
EV/Sales
7.69
Earnings
Revenue
$14.35B
EBIT
$1.95B
EBITDA
$2.29B
Free cash flow
$2.79B
Per share
EPS
$4.26
Free cash flow per share
$7.43
Book value per share
$34.82
Revenue per share
$38.22
TBVPS
$42.6
Balance sheet
Total assets
$34.33B
Total liabilities
$21.25B
Debt
$13.99B
Equity
$13.08B
Working capital
$4.67B
Liquidity
Debt to equity
1.07
Current ratio
1.93
Quick ratio
1.14
Net debt/EBITDA
4.82
Margins
EBITDA margin
16%
Gross margin
63.1%
Net margin
11.1%
Operating margin
15.5%
Efficiency
Return on assets
5%
Return on equity
12.3%
Return on invested capital
9.6%
Return on capital employed
6.7%
Return on sales
13.6%
Dividend
Dividend yield
0.91%
DPS
$2.41
Payout ratio
56.6%

SYK stock price

How has the Stryker stock price performed over time
Intraday
-0.09%
1 week
2.64%
1 month
15.03%
1 year
44.63%
YTD
7.7%
QTD
8.35%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$14.35B
Gross profit
$9.06B
Operating income
$2.22B
Net income
$1.6B
Gross margin
63.1%
Net margin
11.1%
SYK's net income is down by 23% year-on-year and by 9% since the previous quarter
SYK's net margin is down by 21% YoY and by 10% from the previous quarter
The operating income has declined by 18% year-on-year and by 8% since the previous quarter
Stryker's operating margin has decreased by 15% YoY and by 9% QoQ

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
P/E
61.95
P/B
7.58
P/S
6.91
EV/EBIT
56.47
EV/EBITDA
48.1
EV/Sales
7.69
SYK's P/E is 70% above its 5-year quarterly average of 36.4 and 44% above its last 4 quarters average of 43.2
Stryker's EPS has decreased by 24% YoY and by 9% from the previous quarter
SYK's P/B is 33% above its 5-year quarterly average of 5.7 and 31% above its last 4 quarters average of 5.8
SYK's equity is up by 2.2% year-on-year
The stock's price to sales (P/S) is 44% more than its 5-year quarterly average of 4.8 and 33% more than its last 4 quarters average of 5.2
The company's revenue fell by 3.6% YoY

Efficiency

How efficient is Stryker business performance
Stryker's ROIC has decreased by 36% YoY and by 15% from the previous quarter
The ROA has contracted by 34% YoY and by 12% from the previous quarter
The ROE fell by 28% YoY and by 10% QoQ
Stryker's ROS has decreased by 21% YoY and by 13% from the previous quarter

Dividends

What is SYK's dividend history
DPS
$2.41
Dividend yield
0.91%
Payout ratio
56.6%
Recent dividends

Financial health

How did Stryker financials performed over time
The total assets is 62% greater than the total liabilities
SYK's quick ratio is down by 44% from the previous quarter and by 31% YoY
The current ratio has declined by 33% since the previous quarter and by 23% year-on-year
SYK's debt is 7% more than its equity
SYK's debt is up by 26% YoY and by 7% from the previous quarter
The debt to equity has grown by 23% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.